The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Intrinsic immunity: a front-line defense against viral attack
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1×
“A parallel is the rather broad specificity with which Toll-like receptors recognize their ligands and trigger innate immune response”
BackgroundIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
The tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B
Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., & Goff, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90637-6 · Cited by 802
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
Stopak, K., de Noronha, C., Yonemoto, W., & Greene, W. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00353-8 · Cited by 732
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 708
Assembly and Analysis of Conical Models for the HIV-1 Core
Ganser, B. K., Li, S., Klishko, V. Y., Finch, J. T., & Sundquist, W. I. (1999) · Science · doi:10.1126/science.283.5398.80 · Cited by 671
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
Sayah, D. M., Sokolskaja, E., Berthoux, L., & Luban, J. (2004) · Nature · doi:10.1038/nature02777 · Cited by 662
Hypermutation of HIV-1 DNA in the Absence of the Vif Protein
Lecossier, D., Bouchonnet, F., Clavel, F., & Hance, A. J. (2003) · Science · doi:10.1126/science.1083338 · Cited by 651
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 619
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 597
Positional cloning of the mouse retrovirus restriction gene Fvl
Best, S., Tissier, P. L., Towers, G., & Stoye, J. P. (1996) · Nature · doi:10.1038/382826a0 · Cited by 493
Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., & Gabuzda, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313093200 · Cited by 474
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
Inhibition of Retroviral RNA Production by ZAP, a CCCH-Type Zinc Finger Protein
Gao, G., Guo, X., & Goff, S. P. (2002) · Science · doi:10.1126/science.1074276 · Cited by 469
The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G
Conticello, S. G., Harris, R. S., & Neuberger, M. S. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.034 · Cited by 469
Trim5α protein restricts both HIV-1 and murine leukemia virus
Yap, M. W., Nisole, S., Lynch, C., & Stoye, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402876101 · Cited by 455
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 446
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435
Inhibition of Hepatitis B Virus Replication by APOBEC3G
Turelli, P., Mangeat, B., Jost, S., Vianin, S., & Trono, D. (2004) · Science · doi:10.1126/science.1092066 · Cited by 433
Host-Range Restrictions of Murine Leukemia Viruses in Mouse Embryo Cell Cultures
Hartley, J. W., Rowe, W. P., & Huebner, R. J. (1970) · Journal of Virology · doi:10.1128/jvi.5.2.221-225.1970 · Cited by 419
A MAJOR GENETIC LOCUS AFFECTING RESISTANCE TO INFECTION WITH MURINE LEUKEMIA VIRUSES
Pincus, T., Hartley, J. W., & Rowe, W. P. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.6.1219 · Cited by 394
Expression of the Zinc-Finger Antiviral Protein Inhibits Alphavirus Replication
Bick, M. J., Carroll, J.-W. N., Gao, G., Goff, S. P., Rice, C. M., & MacDonald, M. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11555-11562.2003 · Cited by 384
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
Towers, G. J., Hatziioannou, T., Cowan, S., Goff, S. P., Luban, J., & Bieniasz, P. D. (2003) · Nature Medicine · doi:10.1038/nm910 · Cited by 377
Self-citationRetrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α
Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S., & Bieniasz, P. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402361101 · Cited by 373
Self-citationKeckesova, Z., Ylinen, L. M. J., & Towers, G. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402474101 · Cited by 344
Proteolytic refolding of the HIV‐1 capsid protein amino‐terminus facilitates viral core assembly
von Schwedler, U. K., Stemmler, T. L., Klishko, V. Y., Li, S., Albertine, K. H., Davis, D. R., & Sundquist, W. I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1555 · Cited by 337
A New Ticket for Entry into Budding Vesicles—Ubiquitin
Hicke, L. (2001) · Cell · doi:10.1016/s0092-8674(01)00485-8 · Cited by 320
Schröfelbauer, B., Chen, D., & Landau, N. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307132101 · Cited by 311
Bogerd, H. P., Doehle, B. P., Wiegand, H. L., & Cullen, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307713101 · Cited by 295
TRIM5α mediates the postentry block to N-tropic murine leukemia viruses in human cells
Perron, M. J., Stremlau, M., Song, B., Ulm, W., Mulligan, R. C., & Sodroski, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403364101 · Cited by 290
APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
Zennou, V., Perez-Caballero, D., Göttlinger, H., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12058-12061.2004 · Cited by 281
Self-citationEvidence for a newly discovered cellular anti-HIV-1 phenotype
Simon, J. H. M., Gaddis, N. C., Fouchier, R. A. M., & Malim, M. H. (1998) · Nature Medicine · doi:10.1038/3987 · Cited by 280
Restriction of lentivirus in monkeys
Besnier, C., Takeuchi, Y., & Towers, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172384599 · Cited by 279
Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
Cowan, S., Hatziioannou, T., Cunningham, T., Muesing, M. A., Gottlinger, H. G., & Bieniasz, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162299499 · Cited by 275
Self-citationSvarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W.-S., & Pathak, V. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405761200 · Cited by 268
STUDIES OF GENETIC TRANSMISSION OF MURINE LEUKEMIA VIRUS BY AKR MICE
Rowe, W. P. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.5.1272 · Cited by 262
Species-Specific, Postentry Barriers to Primate Immunodeficiency Virus Infection
Hofmann, W., Schubert, D., LaBonte, J., Munson, L., Gibson, S., Scammell, J., Ferrigno, P., & Sodroski, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10020-10028.1999 · Cited by 250
APOBEC-Mediated Editing of Viral RNA
Bishop, K. N., Holmes, R. K., Sheehy, A. M., & Malim, M. H. (2004) · Science · doi:10.1126/science.1100658 · Cited by 247
A conserved mechanism of retrovirus restriction in mammals
Towers, G., Bock, M., Martin, S., Takeuchi, Y., Stoye, J. P., & Danos, O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200286297 · Cited by 246
Madani, N., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10251-10255.1998 · Cited by 245
The Interaction between HIV-1 Gag and APOBEC3G
Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., & Kleiman, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402062200 · Cited by 244
Receptor interference groups of 20 retroviruses plating on human cells
Sommerfelt, M. A., & Weiss, R. A. (1990) · Virology · doi:10.1016/0042-6822(90)90230-o · Cited by 240
Alce, T. M., & Popik, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400235200 · Cited by 239
A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action
Mangeat, B., Turelli, P., Liao, S., & Trono, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400060200 · Cited by 239
Xu, H., Svarovskaia, E. S., Barr, R., Zhang, Y., Khan, M. A., Strebel, K., & Pathak, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400830101 · Cited by 238
Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles
Butler, S. L., Johnson, E. P., & Bushman, F. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3739-3747.2002 · Cited by 238
A dominant block to HIV-1 replication at reverse transcription in simian cells
Münk, C., Brandt, S. M., Lucero, G., & Landau, N. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212400099 · Cited by 231
Restriction of multiple divergent retroviruses by Lv1 and Ref1
Hatziioannou, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg042 · Cited by 229
Cytoplasmic Recruitment of INI1 and PML on Incoming HIV Preintegration Complexes
Turelli, P., Doucas, V., Craig, E., Mangeat, B., Klages, N., Evans, R., Kalpana, G., & Trono, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00255-6 · Cited by 224
Schäfer, A., Bogerd, H. P., & Cullen, B. R. (2004) · Virology · doi:10.1016/j.virol.2004.08.006 · Cited by 223
Göttlinger, H. G., Dorfman, T., Cohen, E. A., & Haseltine, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7381 · Cited by 192
Bouhamdan, M., Benichou, S., Rey, F., Navarro, J. M., Agostini, I., Spire, B., Camonis, J., Slupphaug, G., Vigne, R., Benarous, R., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.697-704.1996 · Cited by 172
Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production
Varthakavi, V., Smith, R. M., Bour, S. P., Strebel, K., & Spearman, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2433165100 · Cited by 167
Mansky, L. M., Preveral, S., Selig, L., Benarous, R., & Benichou, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7039-7047.2000 · Cited by 167
Kozak, C. A., & Chakraborti, A. (1996) · Virology · doi:10.1006/viro.1996.0604 · Cited by 160
Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1
Schwartz, O., Maréchal, V., Friguet, B., Arenzana‐Seisdedos, F., & Heard, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3845-3850.1998 · Cited by 160
Owens, C. M., Yang, P. C., Göttlinger, H. G., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.726-731.2003 · Cited by 137
Use of a Transient Assay for Studying the Genetic Determinants of Fv1 Restriction
Bock, M., Bishop, K. N., Towers, G. J., & Stoye, J. P. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7422-7430.2000 · Cited by 131
Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses
DesGroseillers, L., & Jolicoeur, P. (1983) · Journal of Virology · doi:10.1128/jvi.48.3.685-696.1983 · Cited by 129
Selig, L., Bénichou, S., Rogel, M. E., Wu, L. I., Vodicka, M. A., Sire, J., Bénarous, R., & Emerman, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4842-4846.1997 · Cited by 129
Late viral interference induced by transdominant Gag of an endogenous retrovirus
Mura, M., Murcia, P. R., Caporale, M., Spencer, T. E., Nagashima, K., Rein, A. R., & Palmarini, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402877101 · Cited by 119
BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5δ
Xu, L., Yang, L., MOITRA, P. K., Hashimoto, K., Rallabhandi, P., Kaul, S. C., Meroni, G., Jensen, J. P., Weissman, A. M., & D’Arpa, P. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00187-3 · Cited by 113
Ikeda, H., & Sugimura, H. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5405-5412.1989 · Cited by 111
A major genetic locus affecting resistance to infection with murine leukemia viruses
Pincus, T., Hartley, J. W., & Rowe, W. P. (1975) · Virology · doi:10.1016/0042-6822(75)90039-2 · Cited by 110
APOBEC3G Targets Specific Virus Species
Kobayashi, M., Takaori‐Kondo, A., Shindo, K., Abudu, A., Fukunaga, K., & Uchiyama, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8238-8244.2004 · Cited by 106
Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro
Pryciak, P. M., & VARMUS, H. E. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.5959-5966.1992 · Cited by 92
Willetts, K. E., Gondois‐Rey, F., Agostini, I., Navarro, J., Baudat, Y., Vigne, R., & Sire, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1682-1688.1999 · Cited by 82
Dorfman, T., & Göttlinger, H. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5751-5757.1996 · Cited by 80
Declève, A., Niwa, O., Gelmann, E. P., & Kaplan, H. S. (1975) · Virology · doi:10.1016/0042-6822(75)90038-0 · Cited by 79
FV-4: a new gene affecting the splenomegaly induction by Friend leukemia virus.
Suzuki, S. (1975) · PubMed · Cited by 79
As 2 O 3 Enhances Retroviral Reverse Transcription and Counteracts Ref1 Antiviral Activity
Berthoux, L., Towers, G. J., Gurer, C., Salomoni, P., Pandolfi, P. P., & Luban, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.3167-3180.2003 · Cited by 73
Ganser, B. K., Cheng, A., Sundquist, W. I., & Yeager, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg276 · Cited by 67
Durán-Troise, G., Bassin, R. H., Rein, A. R., & Gerwin, B. I. (1977) · Cell · doi:10.1016/0092-8674(77)90035-6 · Cited by 65
Identification of the Regions of Fv1 Necessary for Murine Leukemia Virus Restriction
Bishop, K. N., Bock, M., Towers, G. J., & Stoye, J. P. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5182-5188.2001 · Cited by 64
Natural and iatrogenic variation in hepatitis B virus
Ngui, S. L., Hallet, R., & Teo, C. G. (1999) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(199907/09)9:3<183::aid-rmv248>3.0.co;2-p · Cited by 52
Bassin, R. H., Durán-Troise, G., Gerwin, B. I., & Rein, A. R. (1978) · Journal of Virology · doi:10.1128/jvi.26.2.306-315.1978 · Cited by 39
Intracellular localisation of Fv1
Yap, M. W., & Stoye, J. P. (2003) · Virology · doi:10.1016/s0042-6822(02)00053-3 · Cited by 23
Taylor, W. R., & Stoye, J. P. (2004) · BMC Structural Biology · doi:10.1186/1472-6807-4-1 · Cited by 21
Differential Association of Uracil DNA Glycosylase with SIVSMVpr and Vpx Proteins
Sleigh, R., Sharkey, M. E., Newman, M. A., Hahn, B. H., & Stevenson, M. (1998) · Virology · doi:10.1006/viro.1998.9159 · Cited by 17
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens
Finlay, B. B., & McFadden, G. (2006) · Cell · doi:10.1016/j.cell.2006.01.034 · Cited by 904
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
Simon, V., Ho, D. D., & Abdool Karim, Q. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69157-5 · Cited by 730
Pichlmair, A., & Reis e Sousa, C. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.012 · Cited by 693
Huang, I.-C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X., Dong, L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001258 · Cited by 603
Metadata
- Authors
- Bieniasz, P. D.
- Venue
- Nature Immunology
- Published
- 2004-10-20
- Volume
- 5
- Issue
- 11
- Pages
- 1109-1115
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1965048581
- Cited by
- 454
- References
- 89
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.